Twin Peaks Wealth Advisors LLC Has $543,000 Stock Position in McKesson Co. (NYSE:MCK)

Twin Peaks Wealth Advisors LLC increased its stake in McKesson Co. (NYSE:MCK) by 2.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 953 shares of the company’s stock after acquiring an additional 26 shares during the quarter. Twin Peaks Wealth Advisors LLC’s holdings in McKesson were worth $543,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Synergy Asset Management LLC acquired a new position in McKesson in the fourth quarter valued at approximately $32,000. MidAtlantic Capital Management Inc. acquired a new position in McKesson in the third quarter valued at approximately $29,000. Crews Bank & Trust acquired a new position in McKesson in the fourth quarter valued at approximately $33,000. RPg Family Wealth Advisory LLC acquired a new position in McKesson in the third quarter valued at approximately $31,000. Finally, Creative Capital Management Investments LLC acquired a new position in McKesson in the fourth quarter valued at approximately $44,000. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Trading Up 1.2 %

Shares of McKesson stock opened at $604.90 on Tuesday. The stock has a fifty day simple moving average of $589.71 and a 200 day simple moving average of $562.02. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51. The company has a market capitalization of $75.81 billion, a P/E ratio of 27.70, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, analysts predict that McKesson Co. will post 32.77 EPS for the current year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be paid a $0.71 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a yield of 0.47%. McKesson’s dividend payout ratio (DPR) is presently 13.00%.

Analyst Ratings Changes

Several equities analysts have issued reports on MCK shares. Citigroup dropped their price target on McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Bank of America lowered their target price on McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Morgan Stanley upped their target price on McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 17th. Evercore ISI upped their target price on McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a research report on Thursday, February 6th. Finally, Baird R W raised McKesson from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 7th. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $645.79.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the company’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $600.66, for a total value of $5,382,514.26. Following the completion of the transaction, the chief executive officer now owns 69,625 shares in the company, valued at $41,820,952.50. This represents a 11.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Leann B. Smith sold 188 shares of the company’s stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the transaction, the executive vice president now owns 1,051 shares of the company’s stock, valued at $640,679.09. This trade represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 19,268 shares of company stock worth $11,536,378 in the last quarter. 0.11% of the stock is currently owned by company insiders.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.